1996
DOI: 10.1002/(sici)1098-2264(199602)15:2<134::aid-gcc9>3.3.co;2-x
|View full text |Cite
|
Sign up to set email alerts
|

The DDX1 gene maps within 400 kbp 5′ to MYCN and is frequently coamplified in human neuroblastoma

Abstract: Human neuroblastoma cells frequently show amplification of the oncogene MYCN, which maps to 2p24. Previous studies have localized the DEAD box motif gene DDX1 to the same chromosome band and demonstrated coamplification of DDX1 and MYCN in two retinoblastoma cell lines. Recently, a high frequency of coamplification of DDX1 and MYCN has been shown in human neuroblastoma cells. We have determined the physical distance between the two genes by pulsed field gel electrophoresis in normal tissue and have found that … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
17
0

Year Published

1997
1997
2011
2011

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(19 citation statements)
references
References 0 publications
2
17
0
Order By: Relevance
“…However, it is also possible that more than one gene can exist as a tumor-specific gene in the same amplicon. For example, PDGFRA has been found to be co-amplified with KIT , along with the vascular endothelial growth factor receptor gene KDR , at 4q12, and DDX1 and N-Myc are co-amplified at 2p24 (33). The co-amplification of multiple genes within a genomic region may have synergistic effects on neoplastic pathogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…However, it is also possible that more than one gene can exist as a tumor-specific gene in the same amplicon. For example, PDGFRA has been found to be co-amplified with KIT , along with the vascular endothelial growth factor receptor gene KDR , at 4q12, and DDX1 and N-Myc are co-amplified at 2p24 (33). The co-amplification of multiple genes within a genomic region may have synergistic effects on neoplastic pathogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…The DDX1 gene has been mapped to chromosome 2p24, ϳ400 kb telomeric to the proto-oncogene MYCN (Amler et al, 1996;Kuroda et al, 1996;Noguchi et al, 1996;Pandita et al, 1997). MYCN, a member of the myc family of transcription factors, is amplified and overexpressed in approximately one-third of all neuroblastoma (NB) tumors as well as in Ͻ10% of RB tumors (Brodeur et al, 1984;Seeger et al, 1985;Sakai et al, 1988;Doz et al, 1996).…”
Section: Introductionmentioning
confidence: 99%
“…HnRNP U or scaffold attachment factor A, a protein located in the nuclear matrix, has recently been shown to function as a repressor of RNA polymerase II elongation by inhibiting transcription factor TFIIH-mediated carboxyl-terminal domain phosphorylation (Kim and Nikodem, 1999). Interestingly, the domain common to both hnRNP U and DDX1 was found to mediate binding of TFIIH to the RNA polymerase II holoenzyme.The DDX1 gene has been mapped to chromosome 2p24, ϳ400 kb telomeric to the proto-oncogene MYCN (Amler et al, 1996;Kuroda et al, 1996;Noguchi et al, 1996;Pandita et al, 1997). MYCN, a member of the myc family of transcription factors, is amplified and overexpressed in approximately one-third of all neuroblastoma (NB) tumors as well as in Ͻ10% of RB tumors (Brodeur et al, 1984;Seeger et al, 1985;Sakai et al, 1988;Doz et al, 1996).…”
mentioning
confidence: 99%
“…Previous reports have found elevated levels of DEAD‐box proteins in many tumors including breast cancer, testicular carcinoma, and neuroblastoma 8. In neuroblastoma, DDX1 is often, but not always, coamplified with the MYCN oncogene, due to close physical proximity to the MYCN oncogene 22, 23. MYCN amplification in neuroblastoma is strongly associated with poor disease prognosis.…”
Section: Discussionmentioning
confidence: 98%
“…8 In neuroblastoma, DDX1 is often, but not always, coamplified with the MYCN oncogene, due to close physical proximity to the MYCN oncogene. 22,23 MYCN amplification in neuroblastoma is strongly associated with poor disease prognosis. However, large series have shown that DDX1 coamplification with MYCN can actually result in improved clinical outcome.…”
Section: Discussionmentioning
confidence: 99%